Ginkgo Bioworks DNA EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's EBITDA?
- Ginkgo Bioworks (DNA) reported EBITDA of -$58.58M in Q1 2026.
- How has Ginkgo Bioworks's EBITDA changed year-over-year?
- Ginkgo Bioworks's EBITDA increased by 11.5% year-over-year, from -$66.15M to -$58.58M.
- What is the long-term trend for Ginkgo Bioworks's EBITDA?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's EBITDA has grown at a -39.1% compound annual growth rate (CAGR), from -$1.8B to -$248.29M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.